USANA Health Sciences, Inc. | February 9, 2021 |
|
● |
Fourth quarter net sales increased 14.5% year-over-year to $310.5 million.
|
|
●
|
Fourth quarter diluted EPS increased 32.6% year-over-year to a record $1.87.
|
|
●
|
Fiscal year net sales increased 7.0% year-over-year to $1.135 billion.
|
|
●
|
Fiscal year diluted EPS increased 32.9% year-over-year to a record $5.86.
|
|
●
|
Company provides 2021 Outlook for Net Sales between $1.21 billion and $1.27 billion and diluted EPS between $6.00 and $6.45.
|
● |
Board of Directors authorizes up to $150 million in share repurchase authorization
|
Consolidated Results
|
||
Net Sales
|
$310.5 million
|
● +14.5% vs.
prior-year quarter
● +9.9% constant
currency vs. prior-year quarter
● +$12.4 million FX
impact, or +4.6%
● Additional week of
sales contributed approximately $18 million
|
Diluted EPS
|
$1.87
|
● +32.6% vs.
prior-year quarter
● Diluted shares of
21.2 million, -2.6%
● Additional week of
sales contributed an estimated $0.17
|
Active Customers
|
599,000
|
● +2.2% vs. prior-year quarter
|
Asia Pacific Region
|
||
Net Sales
|
$248.8 million
|
● +14.5% vs.
prior-year quarter
● Constant currency
net sales: +8.7%
● +$12.5 million FX
impact, or +5.8%
● 80.1% of
consolidated net sales
|
Active Customers
|
454,000
|
● -1.1% vs. prior-year
quarter
|
Asia Pacific Sub-Regions
|
||
Greater China
|
||
Net Sales
|
$139.1 million
|
● +5.4% vs. prior-year
quarter
● Constant currency
net sales: -0.6%
|
Active Customers
|
252,000
|
● -13.1% vs.
prior-year quarter
● -11.3% sequentially
|
North Asia
|
||
Net Sales
|
$32.9 million
|
● +17.1% vs.
prior-year quarter
● Constant currency
net sales: +11.5%
|
Active Customers
|
60,000
|
● +7.1% vs.
prior-year quarter
● no change
sequentially
|
Southeast Asia Pacific
|
||
Net Sales
|
$76.9 million
|
● +34.2% vs.
prior-year quarter
● Constant currency
net sales: +28.9%
|
Active Customers
|
142,000
|
● +25.7% vs.
prior-year quarter
● -10.1% sequentially
|
Americas and Europe Region
|
||
Net Sales
|
$61.7 million
|
● +14.3% vs.
prior-year quarter
● Constant currency
net sales: +14.5%
● -$0.1 million FX
impact, or -0.2%
● 19.9% of
consolidated net sales
|
Active Customers
|
145,000
|
● +14.2% vs.
prior-year quarter
● -2.0% sequentially
|
Consolidated Results
|
||
Net Sales
|
$1.135 billion
|
● +7.0% vs. prior year
● +6.9% constant
currency vs. prior year
● no meaningful FX
impact
|
Diluted EPS
|
$5.86
|
● +32.9% vs. prior
year
● Diluted shares of
21.3 million, -6.8%
|
Cash & Cash Equivalents
|
$312 million
|
● Cash generated from
operating activities totaled $160 million
|
Fiscal Year 2021 Outlook
|
|
Range
|
|
Consolidated Net Sales
|
$1.21 - $1.27 billion
|
Diluted EPS
|
$6.00 - $6.45
|
●
|
A favorable currency exchange rate impact on net sales of approximately $66 million;
|
●
|
An estimated operating margin of between 14.8% and 15.2%;
|
●
|
An annual effective tax rate of 31%; and
|
●
|
An annualized diluted share count of 20.7 million.
|
●
|
Shopping Experience: This will include: (i) website pages and shopping apps in China and worldwide that allow customers to easily find product
information and specific benefits to help them tailor their shopping to their needs/culture/lifestyle and to lead to an increase in sales conversions; (ii) recommendation tools that allow customers to quickly determine which products meet
their needs and lifestyle; and (iii) promotion tools that allow our international markets to quickly design and run unique product offerings tailored to the market’s specific needs.
|
●
|
Customer Communications: We are expanding our text and chat support for our customers at all of our call centers.
|
●
|
Digital Tools and Training: We are working with and training our Associates on how to better utilize various digital tools to create engagement
and grow their business. Examples include: (i) shareable social links that allow Associates to easily introduce and promote products to an interested customer; (ii) improved websites that deliver a branded USANA experience and allow an
Associate to share USANA products and the business opportunity; and (iii) online/digital onboarding through a comprehensive training platform that makes it easy for Associates to become educated on the available digital tools to attract
and service customers.
|
●
|
Digital Transformation: We will continue to invest and
ensure that we are providing our customers and Associates with the best digital tools for online shopping and business building in China. Additionally, our plans include investments in our creative and content management capabilities
within our Beijing facility. These investments will focus on: (i) increased brand awareness; (ii) increased content velocity and nimbleness; and (iii) greater control of the creative process.
|
●
|
Product Innovation: We plan to launch several new
products in China during 2021. In addition to innovating within our current product categories, we plan to explore a broader offering of Traditional Chinese Medicine (“TCM”) products through internal development and pursuing third party
collaborations. A collaboration of this nature could enable us to move to the forefront in the TCM market and allow for the launch of several new products starting in early 2022.
|
●
|
Customer Experience/Branch Office Innovation: Several
of our 29 branch offices in China will be transformed over the next five years into to an experiential store where we will provide enhanced interactive product displays, fitness and health coaching, and biometric screening. Our customers
are interested in having a unique, experiential relationship with our brand and we believe this trial program will help to deliver on customer expectations.
|
●
|
We estimate net sales growth will range between 6% and 12% in this important market during 2021 and we plan to leverage these efforts to
accelerate growth in future years.
|
Investors contact:
|
Patrique Richards
|
Investor Relations
|
|
(801) 954-7823
|
|
investor.relations@us.usana.com
|
|
Media contact:
|
Dan Macuga
|
Public Relations
|
|
801-954-7280
|